[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Why wait for end organ damage to treat myeloma? New IMWG guidelines allow earlier intervention with Dr. Vincent Rajkumar, MD Mayo Clinic

Why wait for end organ damage to treat myeloma? New IMWG guidelines allow earlier intervention with Dr. Vincent Rajkumar, MD Mayo Clinic image

Why wait for end organ damage to treat myeloma? New IMWG guidelines allow earlier intervention with Dr. Vincent Rajkumar, MD Mayo Clinic

Podcast
event Nov 20, 2014 / 11:00AM MST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Vincent Rajkumar, MD Mayo Clinic Interview Date: November 20

 Dr. Vincent Rajkumar, MD, of the Mayo Clinic shares the very large number of changes by the International Myeloma Working Group for the treatment of myeloma. This is a group created by the IMF with over 180 myeloma specialists who are weighing in to change the 2003 treatment guidelines that reflect the advancements made in myeloma care and better diagnostic tools. With deeper diagnostics and more knowledge about how and when myeloma will progress, myeloma specialists want to intervene early and prevent serious end-organ damage (bone and kidney) when they know the myeloma will ultimately progress. The new guidelines strike a delicate balance to allow earlier detection yet are careful that the new guidelines will not mean an increase in false-positive diagnoses.  Major changes were made in the lengthy paper he discusses. There are more definitions for separating MGUS patients into risk categories, new treatment standards for those with a solitary plasmacytoma (single lesion) and more clear definitions for smoldering myeloma patients. He notes an interesting fact, that smoldering myeloma patients' risk goes down the longer that they have had smoldering myeloma that does not progress. Dr. Rajkumar gives an excellent explanation of the detailed changes that is easy to understand. There is much to learn and share (with other patients and YOUR oncologist) about these new standards that change the treatment of myeloma.   The mPatient Myeloma Show with Dr. Vincent Rajkumar

Schedule & Agenda

Event panelist Dr. Vincent Rajkumar & Jennifer Ahlstrom
11:00 AM
Discussion
Dr. Vincent Rajkumar & Jennifer Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.